Diagnostic performance of ultrasound in the assessment of parametrial involvement before surgery in cervical cancer patients (diagnostic accuracy study). (1st November 2019)
- Record Type:
- Journal Article
- Title:
- Diagnostic performance of ultrasound in the assessment of parametrial involvement before surgery in cervical cancer patients (diagnostic accuracy study). (1st November 2019)
- Main Title:
- Diagnostic performance of ultrasound in the assessment of parametrial involvement before surgery in cervical cancer patients (diagnostic accuracy study)
- Authors:
- Fischerova, D
Ballaschova, T
Dostalek, L
Frühauf, F
Zikan, M
Slama, J
Kocian, R
Germanova, A
Němejcova, K
Jarkovsky, J
Cibula, D - Abstract:
- Abstract : Introduction/Background: To evaluate the performance of 2-dimensional (2D) ultrasound in preoperative assessment of parametria involvement in patients with cervical cancer planned for primary surgical treatment. Histopathological findings from radical hysterectomy/trachelectomy/parametrectomy were used as a reference standard. Methodology: Patients with biopsy-proven cervical cancer evaluated on ultrasound and planned for primary surgery 01/2004 and 12/2017 were prospectivelly enrolled. The predefined protocol for ultrasound assessment included the presence of tumor, maximum tumor size, tumor-free distance (TFD), the parametrial involvement status, grade of parametrial infiltration and lymph node status. Results: Altogether, 722 patients were included, out of them 77 patients (11%) were excluded for tumor duplicity, absence of index test or reference standard. Data of 645 patients were analysed, 555 early stage cases (T1[except T1b3], T2a1, FIGO 2018) and 90 locally advanced stage (T1b3 and higher [except T2a1], FIGO 2018). The median age was 42 years and BMI was 24.5. Sixty-two patients (10%) underwent neoadjuvant chemotherapy (NACT). The maximum tumor size was 19.5 mm. The histologically confirmed prevalence of infiltrated parametria was 3.9% (25/645), with 12 cases correctly identified by the ultrasound. Ultrasound did not detect 11 cases (1.7%) with microscopic spread (<2 mm) and 2 cases (0.3%) with macroscopic infiltration (2.75 and 10.0 mm). The accuracy ofAbstract : Introduction/Background: To evaluate the performance of 2-dimensional (2D) ultrasound in preoperative assessment of parametria involvement in patients with cervical cancer planned for primary surgical treatment. Histopathological findings from radical hysterectomy/trachelectomy/parametrectomy were used as a reference standard. Methodology: Patients with biopsy-proven cervical cancer evaluated on ultrasound and planned for primary surgery 01/2004 and 12/2017 were prospectivelly enrolled. The predefined protocol for ultrasound assessment included the presence of tumor, maximum tumor size, tumor-free distance (TFD), the parametrial involvement status, grade of parametrial infiltration and lymph node status. Results: Altogether, 722 patients were included, out of them 77 patients (11%) were excluded for tumor duplicity, absence of index test or reference standard. Data of 645 patients were analysed, 555 early stage cases (T1[except T1b3], T2a1, FIGO 2018) and 90 locally advanced stage (T1b3 and higher [except T2a1], FIGO 2018). The median age was 42 years and BMI was 24.5. Sixty-two patients (10%) underwent neoadjuvant chemotherapy (NACT). The maximum tumor size was 19.5 mm. The histologically confirmed prevalence of infiltrated parametria was 3.9% (25/645), with 12 cases correctly identified by the ultrasound. Ultrasound did not detect 11 cases (1.7%) with microscopic spread (<2 mm) and 2 cases (0.3%) with macroscopic infiltration (2.75 and 10.0 mm). The accuracy of ultrasound in parametrial detection reached 97% with diagnostic odds ratio 62.7. Conclusion: Ultrasound is very good method for preoperative assessment of parametrial involvement in cervical cancer with a minimal risk of failure to detect infiltration >2 mm. Disclosure: This work was supported by Charles University in Prague (UNCE 204065 and PROGRES Q28/LF1) and by a grant from the Czech Research Council (No 16-31643A). None of the authors declare any conflict of interest. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 29(2019)Supplement 4
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 29(2019)Supplement 4
- Issue Display:
- Volume 29, Issue 4 (2019)
- Year:
- 2019
- Volume:
- 29
- Issue:
- 4
- Issue Sort Value:
- 2019-0029-0004-0000
- Page Start:
- A19
- Page End:
- A20
- Publication Date:
- 2019-11-01
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2019-ESGO.22 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19762.xml